ACCP Leadership Development Program

The American College of Clinical Pharmacology® is no longer accepting applications for the 2022 ACCP Leadership Development Program. The call for applications for 2023 will be sent in late Q3 of 2023.

The purpose of this program is to provide a structured experience for individual professional growth in the global clinical pharmacology community as well as a pipeline of potential future ACCP Leaders. The ACCP Leadership Development Committee will review the applications and select participants that most closely align with the requirements. Participants will be notified of acceptance after the selected participants are approved by the ACCP Board of Regents.

The 2022 ACCP Leadership Development Program participants (Kristina Brooks, PharmD; Ayyappa Chaturvedula, PhD, FCP; Brian Cicali, BS, MS; Oliver Grundmann, PhD, FCP, MS, MEd and Alexander Prokopienko, PharmD, PhD ) kindly shared a statement on what they look forward to learning by participating in the program. Please take a few moments to read their statements below.

Testimonials from the 2021 ACCP Leadership Development Program participants can be found here.


Kristina Brooks, PharmD

Kristina Brooks, PharmD

"I am very fortunate to be contributing to and leading multiple studies at my career stage, but I have increasingly felt a need to further develop leadership skills and confidence after transitioning from a trainee to early-stage investigator role. ACCP’s Leadership Development Program will offer an excellent opportunity to further develop leadership skills so I can ensure both continued success in academia and contributions to ACCP through new leadership and committee roles."

Ayyappa Chaturvedula, PhD, FCP

Ayyappa Chaturvedula, PhD, FCP

"I hope to learn strategic thinking and principles of scientific leadership from the ACCP Leadership Development Program. My goal is to evolve as a leader in drug development with a core expertise in clinical pharmacology and pharmacometrics."

Brian Cicali, BS, MS

Brian Cicali, BS, MS

"By participating in the American College of Clinical Pharmacology® Leadership Development Program, Brian hopes to learn skills that will both make him a better leader and aid in his transition from PhD candidate to early-career professional. In doing so, he hopes to achieve a greater understanding of good leadership qualities and how to apply these to his professional activities. By learning and applying the leadership skills obtained in this program, he believes he will be better equipped to not only be a great leader within his professional positions, but also within service positions such as future leadership roles within ACCP."


Oliver Grundmann, PhD, FCP, MS, MEd

Oliver Grundmann, PhD, FCP, MS, MEd

"One outcome I hope to gain from the program is to further develop a sense of leadership style that allows me to embrace team work while not losing sight of the end goal. A critical component of leadership is to manage individual strengths to the advantage of the team, which is a central value of the volunteer work at ACCP to drive many operations and projects efficiently and effectively. Being an effective leader will often require understanding my own limitations along with my strengths, which I hope to better comprehend and navigate upon completion of the program to optimize my productivity and long-term strategic planning/thinking. Leadership does also encompass enabling others, stepping back to entrust another person with leading an effort is an approach I would like to learn more about and incorporate into my leadership style."

Alexander Prokopienko, PharmD, PhD

Alexander Prokopienko, PharmD, PhD

"I am excited to participate in the Leadership Development Program in order to learn and grow as a leader. I look forward to learning strategies to be a more effective leader who inspires people and teams. Finally, I am grateful to ACCP and humbled for the opportunity to participate in this program – I plan to be a strong leader and advocate for clinical pharmacology through active engagement with ACCP in the future."